Offer CAS.NO:58-14-0 C12H13ClN4 Pyrimethamine CAS NO.58-14-0

Min.Order Quantity:: 16 Metric Ton

Purity:: 85%-99% purity

Port:: any Chinese port

Payment Terms:: L/C,D/A,D/P,T/T,

Add to Inquiry Cart

Product Details

Keywords

Supply 58-14-0
Sale 58-14-0
Offer 58-14-0

Quick Details

ProName: Offer CAS.NO:58-14-0 C12H13ClN4 Pyri...
CasNo: 58-14-0
Molecular Formula: C12H13ClN4
Appearance: White to cream colored powder
Application: 58-14-0
DeliveryTime: Within 7 working days since received y...
PackAge: By 25kg /pp bag or 16tons /20'fcl
Port: any Chinese port
ProductionCapacity: 60 Metric Ton/Day
Purity: 85%-99% purity
Storage: Dry and cool environment
Transportation: by sea
LimitNum: 16 Metric Ton
FULL NAME:: Sodium Carboxymethyl Cellulose
Type:: Emulsifiers, Stabilizers, Thickeners
Appearance:: White to cream colored powder

Superiority

58-14-0

Details

pyrimethamine basic information

antiprotozoal veterinary drug role and purpose pharmacokinetics adverse reactions precautions medicine interactions dosage uses

product name:	pyrimethamine
synonyms:	2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidine;2,4-diamino-5-chlorophenyl-6-ethylpyrimidine;2,4-pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-;2,4-pyrimidinediamine, 5-(p-chlorophenyl)-6-ethyl-;2,4-pyrimidinediamine,5-(4-chlorophenyl)-6-ethyl-;4753 r.p.;4753r.p.;5-(4’-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
cas:	58-14-0
mf:	c12h13cln4
mw:	248.71
einecs:	200-364-2
product categories:	apis & intermediate;pyrimidine;organics;amines;bases & related reagents;heterocycles;intermediates & fine chemicals;nucleotides;pharmaceuticals;inhibitor;heterocycle-pyrimidine series;daraprim
mol file:	58-14-0.mol

pyrimethamine chemical properties

mp	233-234°c
storage temp.	0-6°c
water solubility	<0.01 g/100 ml at 21 ºc
stability:	stable, but light sensitive. combustible. incompatible with strong oxidizing agents.
cas database reference	58-14-0(cas database reference)
nist chemistry reference	pyrimethamine(58-14-0)
epa substance registry system	2,4-pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl- (58-14-0)

safety information

hazard codes	xn
risk statements	22
ridadr	3249
wgk germany	3
rtecs	uv8140000
hazardclass	6.1(b)
packinggroup	iii

msds information

provider	language
2,4-diamino-5-(p-chlorophenyl)-6-ethylpyrimidine	english
sigmaaldrich	english

pyrimethamine usage and synthesis

antiprotozoal veterinary drug	pyrimethamine is a widely used broad-spectrum antiprotozoal veterinary medicine. in addition to this, pyrimethamine can also be applied to the breeding of the aquatic product and is also capable of enhancing the disease resistance capability of aquaculture fish. however, pyrimethamine has significant side effects with being used in excess amount being able to cause damage to the reproductive system of livestock and poultry, and is also difficult for recovery. pyrimethamine has inhibitory effect on the primary exo-erythrocytic stage of plasmodium falciparum and vivax malaria, and is a good preventive medicine. although it has no significant effects on the malaria gametocyte but when the drug-containing blood enters into the mosquito body, it can affect the development of gametocytes inside mosquitoes, thus being able to interrupt the transmission. the mechanism of action is to inhibit the dihydrofolate reductase and affect the utilization of folate, causing reduction of the nucleic acid synthesis and inhibiting the malaria parasite reproduction. meanwhile pyrimethamine and chloroquine, through lowering the level of oxidative stress and apoptosis, can exert protective effect on the placental pathology after the infection of malaria and can also reduce the proportion of infected red cells in the blood, therefore being able to achieving a excellent therapeutic effect on malaria. it also has enrichment effect in aquatic body. upon going beyond a certain range, it can cause hemolytic anemia after being eaten and even has direct toxicity on the central nervous system. this product is mainly used for the prevention of malaria and can also be used for the treatment of toxoplasmosis. it has inhibitory effects on the primary exo-erythrocytic stage of some kinds of plasmodium falciparum and vivax malaria and is a good preventive medicine. owing to its slow excretion rate, it has a long-lasting effect with the preventive effect of one-time medication being able to be maintained for more than 1 week. although this product has no significant effects on the malaria gametocyte but when the drug-containing blood is inhaled into the mosquito body, it can affect the development of gametocytes inside mosquitoes, thus being able to interrupt the transmission. because of its effect on inhibiting the exo-erythrocytic stage of plasmodium, it is usually used in combination with primaquine for the prevention of recurrence. this product appears as white crystalline powder; it is odorless and tasteless. it is insoluble in water, slightly soluble in ethanol, chloroform and acetone and soluble in dilute acid. it has a melting point of 232 ~ 235 ℃. figure 1 is a structural formula of pyrimethamine
role and purpose	this product can inhibit dihydrofolate reductase, causing failure of the conversion from dihydrofolate into tetrahydrofolate, resulting in decreased synthesis of nucleic acid, so that the parasite propagation is inhibited. it is mainly used for the prevention of malaria, it can also be combined with primaquine to prevent relapse of malaria.
pharmacokinetics	after oral administration, gastrointestinal absorption is complete but very slow with the blood concentration reaching peak after four hours. plasma protein has a binding rate of 80%. it is mainly distributed in tissues such as liver, lung, kidney and other tissues as well as in milk. the half-life is about 90 hours with only 10% to 20% of the prototype drug being excreted through the urine at 5 to 7 days after administration. the effective concentration of the blood can be maintained for two weeks. therefore, single-time medication can has its preventive effect be maintained for more than 1 week.
adverse reactions	1. upon administration of high dose can cause acute poisoning symptoms such as fatigue, nausea, vomiting, abdominal pain, fever, cyanosis, jaundice, splenomegaly, etc. upon this condition, drug administration should be promptly discontinued and the patients should be subject to gastric lavage, rehydration and symptomatic treatment. because of the sweet taste of this product, it is more prone for children to be subject to mistakenly administration and poisoning, special attention should be paid. 2. long-term administration can interfere with the in vivo utilization of folic acid, producing megaloblastic anemia. therefore, the patients should be subject to regularly monitoring of blood. if the above issue happens, we should treat with leucovorin.
precautions	1. lactating women and patients of renal dysfunction should take with caution. pregnant women in early phase should be disabled. children less than 1 year of age should not use. 2. this product has slightly fragrance without bitter taste and should be protected from the reach of children whose mistaken administration can lead to poisoning, convulsions (children under age 6 who takes 50 ~ 100mg can get poisoning and die). barbiturates can confront its role in the central excitability. 3. this product, after single-time overdose of long-term continuous administration can cause bone marrow suppression and gastrointestinal function inhibition, resulting in megaloblastic anemia and leukopenia with timely withdrawal leading to self-healing. giving formylation cf may alleviate the bone marrow function. 4. adults, after single dose administration of 150 ~ 200mg have the risk of poisoning. it often occurs of nausea, vomiting, headache, dizziness and other symptoms within 1 to 5 hours with convulsions and coma occurring in severe cases. children under 6 years of age can die upon administration at draught of 50 ~ 100mg and get poisoning and die, it should be given attention. first aid measures: apply gastric lavage, vomiting; drink a lot of sugar or 10% carrot juice. the patients can further subject to administration of the glucose infusion and diuretics. patients of spasms and convulsions should be subject to infusion of thiopental. 5. patients of renal damage, unconsciousness, 6-gpd deficiency and giant cell anemia should take with caution. this information is edited by xiongfeng dai from chemicalbook.
medicine interactions	being used in combination with dihydrofolate synthetase inhibitors (such as sulfadoxine or dapsone) can double block the folate metabolism of malaria parasite and enhance its performance, delay or prevent the emergence of drug-resistant strains of insects. it can’t be used in combination with other kinds of dihydrofolate reductase inhibitor because it can enhance the toxicity.
dosage	prophylaxis: start administration at 1 to 2 weeks before entering into the affected area. it is generally recommended to keep administration to until 6 to 8 weeks after leaving the affected areas once per week and 25 mg per time. children take once per week with 0.9 mg / kg per time with the highest dose limited for adults. for plasmodium falciparum caused chloroquine-resistant strains: take 50 mg daily with 2 times. for children, take 0.3 mg / kg at 3 times per day with the course of three days. toxoplasmosis: daily 50 ~ 100 mg, administrate at draught at a dose of 25 mg after 1 to 3 days with a course of 4 to 6 weeks. for children, take 1 mg/kg with 2 times. after 1-3 days, change to 0.5 mg/kg daily at 2 times with a course of 4 to 6 weeks.
uses	it can be taken as antimalarial drug for the prevention of malaria and anti-retroviral therapy.
chemical properties	white solid
usage	dihydrofolate reductase inhibitor; generally used in combination with other antimicrobial agents. antiprotozoal (toxoplasma); antimalarial
usage	for the treatment of toxoplasmosis and acute malaria; for the prevention of malaria in areas non-resistant to pyrimethamine
general description	odorless white crystalline powder. tasteless. an antimalarial drug.
air & water reactions	insoluble in water.
reactivity profile	pyrimethamine is sensitive to exposure to light . neutralizes acids to form salts plus water in exothermic reactions. may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. flammable gaseous hydrogen may be generated in combination with strong reducing agents, such as hydrides.
fire hazard	flash point data for pyrimethamine are not available; however, pyrimethamine is probably combustible.
biological activity	potent inhibitor of multi-drug and toxin extrusion (mate) transporters (k i values are 46 and 77 nm for human mate2-k-hek293 and mate1-hek293 cells respectively). also inhibits dihydrofolate reductase (dhfr).